CLOSE| Date | Filer | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| Dec 03, 2018 |
EVP & Chief Financial Officer
Trans History: 153
|
EVP & Chief Financial Officer | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 19,385 | -- | 119,457 |
| Feb 18, 2021 |
Director
Trans History: 63
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 19,424 | -- | 98,404 |
| Feb 18, 2021 |
Director
Trans History: 14
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 19,424 | -- | 60,577 |
| Feb 18, 2021 |
Director
Trans History: 27
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 19,424 | -- | 99,497 |
| Feb 18, 2021 |
Director
Trans History: 8
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 19,424 | -- | 44,920 |
| Feb 18, 2021 |
Director
Trans History: 22
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 19,424 | -- | 76,185 |
| Feb 18, 2021 |
Director
Trans History: 66
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 19,424 | -- | 45,827 |
| Feb 18, 2021 |
Director
Trans History: 7
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 19,424 | -- | 35,192 |
| Feb 18, 2021 |
Director
Trans History: 79
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 19,424 | -- | 68,552 |
| Feb 18, 2021 |
Director
Trans History: 98
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 19,424 | -- | 77,547 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.